Post-approval studies (Phase 4)Study completedNCT00688480
What this trial is testing
Do Xanthine Oxidase Inhibitors Reduce Both Left Ventricular Hypertrophy and Endothelial Dysfunction in Cardiovascular Patients With Renal Dysfunction?
Who this might be right for
Kidney DiseaseLeft Ventricular Hypertrophy
A. D. Struthers 67